Merck (MRK) Operating Expenses (2009 - 2026)

Merck (MRK) has reported Operating Expenses for 18 consecutive years, with $12.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 76.33% year-over-year to $12.8 billion in Q2 2026; TTM through Jun 2026 was $38.5 billion, a 29.72% increase from a year earlier, with the FY2025 full-year figure at $27.4 billion, down 5.68% from the prior year.
• Operating Expenses was $12.8 billion for Q2 2026 at Merck, down from $15.5 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $16.2 billion in Q2 2023 and troughed at $3.3 billion in Q4 2025.
• A 5-year average of $7.9 billion and a median of $6.9 billion in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 196.66% in 2023 and sank 60.93% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at $6.5 billion in 2022, then jumped by 31.45% to $8.6 billion in 2023, then retreated by 12.38% to $7.5 billion in 2024, then sank by 56.51% to $3.3 billion in 2025, then jumped by 292.39% to $12.8 billion in 2026.
• The last three Operating Expenses figures came in at $12.8 billion (Q2 2026), $15.5 billion (Q1 2026), and $3.3 billion (Q4 2025), per Business Quant data.